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Abstract
Background: Enabled by rapid advances in sequencing technology, metagenomic studies aim to characterize
entire communities of microbes bypassing the need for culturing individual bacterial members. One major goal of
metagenomic studies is to identify specific functional adaptations of microbial communities to their habitats. The
functional profile and the abundances for a sample can be estimated by mapping metagenomic sequences to the
global metabolic network consisting of thousands of molecular reactions. Here we describe a powerful analytical
method (MetaPath) that can identify differentially abundant pathways in metagenomic datasets, relying on a
combination of metagenomic sequence data and prior metabolic pathway knowledge.
Methods: First, we introduce a scoring function for an arbitrary subnetwork and find the max-weight subnetwork
in the global network by a greedy search algorithm. Then we compute two p values (pabund and pstruct) using
nonparametric approaches to answer two different statistical questions: (1) is this subnetwork differentically
abundant? (2) What is the probability of finding such good subnetworks by chance given the data and network
structure? Finally, significant metabolic subnetworks are discovered based on these two p values.
Results: In order to validate our methods, we have designed a simulated metabolic pathways dataset and show
that MetaPath outperforms other commonly used approaches. We also demonstrate the power of our methods in
analyzing two publicly available metagenomic datasets, and show that the subnetworks identified by MetaPath
provide valuable insights into the biological activities of the microbiome.
Conclusions: We have introduced a statistical method for finding significant metabolic subnetworks from
metagenomic datasets. Compared with previous methods, results from MetaPath are more robust against noise in
the data, and have significantly higher sensitivity and specificity (when tested on simulated datasets). When applied
to two publicly available metagenomic datasets, the output of MetaPath is consistent with previous observations
and also provides several new insights into the metabolic activity of the gut microbiome. The software is freely
available at http://metapath.cbcb.umd.edu.
Background
Metagenomics is a new scientific field that involves the
analysis of organismal DNA sequences obtained directly
from an environmental sample, enabling studies of
microorganisms that are not easily cultured in a labora-
tory [1]. Metagenomic studies, pioneered in the early
2000s [2], have recently increased in number and scope
due to the emergence of next generation sequencing
technologies. Due to the difficulty of assembling entire
organisms from a metagenomic dataset [1], most ana-
lyses take a gene-centric view, treating the community
as an aggregate and ignoring the exact assignment of
genes to individual organisms. In fact, it can be argued
that the environment is better characterized by its gene
complement rather than by its taxonomic composition,
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this view is the observation that, while the taxonomic
composition of the human gut microbiome varies signif-
icantly between people, the functional profile is remark-
ably stable across samples [3]. The functional profile for
a sample can be recovered by mapping sequences to
gene families [4], subsystems [5] or metabolic pathways
[6]. The relative abundance of each functional category
can be estimated by counting how many sequences are
assigned to each category, and this information is the
basis for detailed comparisons of the functional potential
of different functions. In a typical comparative metage-
nomics experiment, random shotgun sequences are gen-
erated from a collection of samples belonging to two
groups, for example, obese or lean twins [3], and healthy
infants or adults [7]. An important biological problem is
to find differentially abundant functional signatures (e.g.,
genes or metabolic pathways) that are selected for by
their local environments. Traditional analysis approaches
compare the relative abundances of the categories one-
at-a-time between different phenotypes, and compute
the significance using one of several statistical
approaches [8-10]. When comparing communities at the
gene family level, many functional categories are com-
monly found to be differentially abundant, even after
correcting for multiple hypothesis testing [3,7]. The
interpretation of these data can be daunting. An alterna-
tive approach focuses on functional subsystems and
metabolic pathway comparisons [11], the number of
which is much smaller than gene families. Results at
these levels are easier to interpret and can provide a
stronger evidence of distinct functional capacities than
at the level of individual gene families. Such analyses,
however, can be unnecessarily coarse. For example, the
use of KEGG pathways as a basis for analysis is compli-
cated by the following issues: (1) the definitions of path-
ways in KEGG are coercive, and the interactions
between these pathways are ignored; (2) the genes in a
p a t h w a ym a yn o tb ef u l l yc o v e r e db yt h ei d e n t i f i e d
genes in a metagenomic sample; (3) significant differ-
ences in the abundance of certain genes may be masked
once the abundance of all genes in a pathway is
aggregated.
To address these problems, we introduce a general
method (MetaPath) for searching the global metabolic
network to find differentially abundant finer-level sub-
networks. For the purposes of this paper we define a
subnetwork to be a connected set of genes that is statis-
tically enriched or depleted in one group of samples.
Underlying our approach is a statistical scoring system
that captures the differential abundance for a given sub-
network, combined with a greedy search algorithm for a
maximum weighted subgraph, to indentify the highest
scoring subnetworks. Unlike previous approaches, Meta-
Path explicitly searches significant subnetwork in the
global metabolic network (rather than the KEGG
defined pathways), enabling us to detect subnetworks
spanning predefined “containers”. In addition, we devel-
oped rigorous statistical methods that take into account
the topology of the network when testing the signifi-
cance of the subnetworks.
Using simulated datasets, we demonstrate that Meta-
path outperforms previously described approaches for
comparing biological networks based on abundance
data. We show that our findings are more robust to
n o i s yd a t at h a nt h er e s u l t so fs i n g l eg e n ec o m p a r i s o n s ,
and that MetaPath can find finer-level subnetwork than
can be found by comparing predefined KEGG pathways.
We also discuss the biological significance of the results
derived from the application of MetaPath to actual
metagenomic datasets, demonstrating that the output
from MetaPath is easy to interpret and provides valuable
biological insights. The software is freely available at
http://metapath.cbcb.umd.edu.
Methods
Datasets
We tested our methods on two previously published
metagenomic datasets, which were downloaded from
the NCBI Trace Archive or Short Read Archive data-
bases: (1) gut microbiomes from obese and lean twins
[3]; (2) metagenomes from adult- and infant-type gut
microbiomes [7]. Each dataset is divided into two popu-
lations of distinct phenotypes. The metabolic pathway
data were downloaded from the KEGG pathways data-
base [6]. The metabolic network is represented as a
graph where nodes are metabolic substrates, and edges
are molecular reactions (Fig. 1). The edges could be
unidirectional or bidirectional depending on whether
the corresponding reaction is reversible (as specified in
KEGG database). Multiple reactions that are related to a
same biological process are aggregated by KEGG into a
“pathway” (e.g., glycolysis pathway). In addition, we
refer to the network comprising all metabolic pathways
in KEGG as the “global metabolic network”. Metage-
nomic sequences are annotated through BLASTX
searches against KEGG genes database. The abundance
of each molecular reaction is estimated as the number
of metagenomic sequences mapped to it. Note that
more accurate abundance estimates can be obtained by
taking into account the length of individual genes [12]
and we plan to explore the use of such estimates (and
the associated statistics) in future versions of our
software.
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Page 2 of 12Figure 1 Schematic diagram of the MetaPath methods.Sequences from each sample are annotated against KEGG genes database
andmapped to reactions in metabolic networks, resulting an abundance matrix where therows are reactions and columns are samples. Then p
values are computed for allreactions using Metastats [9], then converted into Z values, and greedy search isperformed on the edge-weighted
graph to find max-weight subnetworks. Finally, wecalculate the pabund and pstruct significance values of the max-weight subnetwork.
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To score the biological activity of a particular subnet-
work, we first use Metastats [9] to calculate the signifi-
cance of differential abundance for each reaction
between the two phenotypic groups under comparison.
Under the null hypothesis, the relative abundances are
randomly drawn from the same distribution across
different phenotypic groups, thus the p value for each
feature (metabolic reactions) follows a uniform distribu-
tion from 0 to 1. Based on this assumption, p values can
be converted to Z scores [13] using the Gaussian distri-
bution. Because Metastats performs a two-tailed test for
each reaction, the two-tailed p values can be converted
back to the original Z values using the following
equation:
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tion (CDF) of standard normal distribution; G1 and G2
represent two different phenotypic groups. Using this
formula, if a reaction is more abundant in population
G1, then its Z s c o r ew i l lb ep o s i t i v ea n dv i c ev e r s a .W e
are specifically interested in finding a pathway whose
reactions are either enriched or depleted as a whole, as
apposed to previous approaches [13,14] that identify
active or perturbed subnetworks, which may contain a
mixture of enriched and depleted components. Similar
to the approach of [13] we define the aggregate score
for a particular subnetwork to be the sum of the Z
scores over all reactions contained within it: Z
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1 ,w h e r ek is the size (number of meta-
bolic reactions) of the subnetwork.
Identifying high-scoring pathways
As proposed in [13], we attempt to find subnetworks
that maximize the cumulative Z- score defined above.
Unfortunately, this problem is NP-hard, which is equiva-
lent to finding a maximum-weight subgraph [13]. Sev-
eral approaches to solving this problem have been
previously proposed: Ideker, et al. 2002 [13] used simu-
lated annealing, but this heuristic is slow; Dittrich, et al,
2008 [14] used integer linear programming that can find
provably optimal subpathway sq u i c k l y ,b u ti tr e q u i r e s
the commercial software package CPLEX that is not
available to the general public (using a freely available
ILP solver would require re-implementing the entire
algorithm as the software is provided as a binary-only
release). Here we rely on a greedy search heuristic that
is fast, and, while not guaranteed to find maximally
scoring pathways, performs well in practice. The algo-
rithm we employ is described below:
Input : A global metabolic network G=(V, E), where V and
E ar re metabolites (vertices) and reactions (edges); a
set of w weight values Z that are associated with each
edge in graph h G
A max-weight subnetwork G  and its score W max max Output :
1 1 Initialize W  to 0;
 edge e  in E 
Initialize
max
i 2
3
FOREACH DO
   G  by including e ;
4 Initialize W  to be the weight o
now i
now f f e ;
5 Initialize W  to 0;
6  W >=W  
7   W = W
i
pre
now pre
pre
WHILE DO
n now
j     Pick an edge e  which has the highest weight
    a
8
m mong all edges adjacent to G ;
9     Include e  to G ;
1
now
jn o w
0 0     Calculate the score W  of G ;
11 W =W ;
12 G =
now now
now pre
now G G- e ;
13  W >W  
14      W =W ;
15      G =G
now j
now max
max now
max no
IF DO
w w
max max
;
16 Output G  and its score W ;
This algorithm tries to find a connected metabolic
subnetwork, which can have any arbitrary structure,
with maximum weight. However, it is believed that in
metabolic networks, chains are especially more biologi-
cally meaningful and interesting, because they attempt
to capture the structure of a series of reactions that are
successively connected. To allow this idea, we modify
line 8 of the above algorithm to “Pick an edge ej which
has the highest weight of the edges that are adjacent to
and have the same direction with ej-1”.B o t hs e a r c h i n g
algorithms are implemented in our program and can be
selected through command-line parameters. To find all
significant subnetworks (computing significance is dis-
cussed below), we iteratively remove the edges in the
global network that are contained in previously found
significant subnetworks, and rerun our greedy search on
the rest of the network until we can no longer find any
additional significant subnetworks. Note, that unlike the
original version of our code [15], the search algorithm is
not limited to given subnetwork size, rather will find all
significant subnetworks irrespective of size.
Computing the significance of subnetwork
The null score distribution for a specific subnetwork
can be estimated by permuting the sample labels (col-
umns of the abundance matrix) of the reactions and
computing the subnetwork scores from the permuted
abundance matrix. The significance p value is esti-
mated as the number of random permutations that
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The p value computed through this approach (termed
pabund throughout the rest of the paper), however,
ignores the topology of the underlying global metabolic
network, and potentially leads to incorrect conclusions.
For example, assume we have a densely connected
metabolic network, in which every edge is connected
with all other edges. Then, the best subnetwork is sim-
ply composed of the top differentially abundant meta-
bolic reactions. This indicates that whenever there are
significant reactions, which may simply come from
random noise given the large number of edges, they
will form a significant subnetwork because of the
biases from the network topology (Fig. 2). To address
this problem, we compute another p value (termed
pstruct), relying on a topological definition of the null
distribution of subnetwork scores. Specifically, instead
of treating each subnetwork as a bag of genes, we esti-
mate the distribution of scores for actual subnetworks
identified within the underlying global metabolic net-
work. Since this null-distribution depends on the size
(number of edges) of the subnetwork, let k be the size
of a subnetwork generated by the greedy search
algorithm described above, and Z be the corresponding
Z-score. The pstruct value for this subnetwork can be
calculated as follows: (i) permute the edge weights
(row labels of the abundance matrix) of the global
metabolic network; (ii) perform greedy search to find a
maximal weighted subnetwork of size k; (iii) repeat
step 1 and step 2 for 1000 times, and generate 1000
weights of the max-weight subnetwork (null distribu-
tion); (iv) the pstruct value is the proportion of the 1000
times in step 3 that we see scores higher than our ori-
ginal observation Z.
MetaPath methods summary
To summarize the methods described above, the Meta-
Path algorithm proceeds as follows:
1. Differential abundance is assessed on an edge-by-
edge basis (reaction-by-reaction) using Metastats;
2. The significance estimates (p-values) from Metastats
are fed into a greedy search algorithm to determine all
Figure 2 Significant subnetworks that are caused by structural biases.On the left side, both of the two pathways have equal weight,
indicating equalsignificance of differential abundance. The high weight of the second pathway,however, mainly come from the middle fat edge
that has weight 7. On the right side,in a densely connected network, any random high-weight edges will form asubnetwork with high weight
(correlated noise).
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Z-scores) in the global metabolic network;
3. The significance of each subnetwork detected by the
greedy search algorithm is assessed using both a topol-
ogy-independent bootstrapping approach (pabund), and a
topology-dependent bootstrapping approach (pstruct);
4. The subnetworks determined to be significant
(pabund ≤ 0.05 and pstruct ≤ 0.05) are reported to the user
(Note: the threshold for significance can be adjusted
through command-line parameters). The pathways are
ranked by pabund values.
Results and discussions
Performance evaluation using simulated datasets
In order to validate our methods, we have designed a
simulated metagenomic study and compared the results
with three previous approaches: (i) identifying signifi-
cantly active subnetworks using simulated annealing and
greedy search [13]; (ii) discovering significant individual
reactions using Metastats [9]; and (iii) finding differen-
tially abundant KEGG defined pathways, an approach
widely used in metagenomic functional comparison
[3,7,10]. We choose these tools because they are addres-
sing similar biological problems. However they do not
solve the exact same problem as this paper, which is
finding differentially abundant subnetworks that may
span two or more KEGG defined pathways (see discus-
sion in the Background section). Here the goal of this
simulated study is to show that the computational pro-
blem in this paper can not be directly solved by applying
methods previously developed in a related context.
We designed a simulated metabolic pathways dataset
in which five subjects are created for each of the two
groups with distinct phenotypes. To generate the artifi-
cial reaction abundance matrix (where rows represent
reactions and columns represent subjects), a Gaussian
distribution is created for each reaction, whose mean is
randomly chosen from a real metagenomic dataset (gut
microbiome from obese and lean subjects [3]). The var-
iance of each distribution is calculated by setting the
relative standard deviation (standard deviation divided
by the mean) to 0.2. If we define a reaction to be equally
abundant between two groups under comparison, then a
random abundance value is generated from the same
distribution for each subject. Otherwise, if a reaction is
defined to be significantly enriched in one group, then
another normal distribution is created for this reaction
by increasing the mean such that the p value of the dif-
ference for the two distributions is less than a prede-
fined value (0.05 and 0.01 were used). In this study, we
have chosen a subnetwork (a series of reactions with
length 5 or 10) to be enriched in one population. The
goal is to compare different methods in recovering this
significant subnetwork (a set of significant reactions)
based on the simulated abundance matrix. Biologically,
the enriched pathways indicate functional enrichment of
certain biological processes in a microbial community.
The receiver operating characteristic (ROC) curve is
plotted for each method (Fig. 3). Fig. 3 shows that Meta-
Path outperforms all other methods dramatically show-
ing the advantage in finding significant subnetworks.
Note that the results tested on our simulated datasets
can be considered as the baseline performance, because
it contains only one significant subnetwork, whereas real
metagenomic datasets typically contain multiple signifi-
cant pathways. The most commonly used approach —
comparing KEGG-defined pathways — performs the
worst in our simulation study (Fig. 3).
Obese and lean twins
We used MetaPath to compare the abundances of the
metabolic networks of the gut microbiome in lean and
obese subjects, relying on data from [3]. This metage-
nomic dataset comprises 6 samples from obese subjects
and 6 samples from lean objects. The sequences are
annotated and mapped to KEGG reactions using
BLASTX (E value < 10
-5,b i t s c o r e>5 0 ,a n d% i d e n t i t y>
50; parameters suggested in the original study), resulting
in total 1832 unique reactions within the 12 metage-
nomic samples. First, we computed p values [16] using
Metastats to find differentially abundant reactions.
Using a p value cutoff of 0.05, 92.7±9.1 (mean±standard
deviation) reactions are significant including 37.1±6.6
and 55.6±3.1 enriched reactions in obese and lean
groups, respectively, based on 10 runs of Metastats. The
high variance of the number of significant genes can be
primarily explained by two reasons: (1) some reactions
a r es l i g h t l yb e l o wo ra b o v es ignificance cutoff (0.05),
thus p values computed through bootstrapping will
jump between being considered significant and not sig-
nificant (Fig. 4); (2) there are large variances of the
abundance values within individuals in a same phenoty-
pic group. In addition to p values, Metastats also pro-
v i d e sa ne s t i m a t eo ft h eF a l s eD i s c o v e r yR a t e( q value),
information that is not used by MetaPath. The q values
for all reactions are 1 (except R01676 where q=0.73), i.e.
a literal interpretation of Metastats results would indi-
cate no pathways are significantly different between the
two populations. This result can be explained by the flat
distribution of the p values (Fig. 4), from which the q
values are estimated. This observation highlights the
limitation of relying on the false discovery rate, which
requires the estimation of the proportion of features
that are truly null [16], approach that does not perform
well when only few features are truly significant.
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found 9 differentially abundant subnetwork (Fig. 5)
using 0.05 cutoff value for both pabund and pstruct.A l l
these subnetworks are enriched in obese subjects; none
was found to be enriched in lean subjects. These 9 sig-
nificant subnetworks contain 48 unique reactions, 22 of
which are significant. It is worth pointing out that the
number of significant reactions varies between different
runs of statistical permutations (using Metastats) as
shown above, but the significant pathways identified by
Metapath stay the same (Fig. 5). This observation con-
firms that the results from MetaPath are more robust in
the presence of noise in the data than the gene-by-gene
approach. In the p values distribution of subnetworks
(Fig. 4), most of them are either very significant or insig-
nificant and very few are around the p value cutoff,
allowing the users to easily interpret the results.
Five subnetworks (Fig. 5a-5e) are completely contained
in the KEGG Fatty Acid Biosynthesis pathway, which
consists of catabolic processes that can generate energy
and primary metabolites from fatty acids. Our findings
are consistent with previous observations and biochem-
ical analysis in microbiota transplantation experiments
in germ-free mice [17], where the concentrations of
short-chain fatty acids in the caeca of obese mice are
higher than lean mice, suggesting that the gut micro-
biome in obese subjects has an increased capacity for
dietary energy harvest.
Another interesting significant networks consists of 10
reactions (Fig. 5f), of which 8 belong to Cysteine and
Methionine Metabolism and 2 belong to Sulfur Metabo-
lism. Many reactions in this subnetwork are connected
by the L-Homocysteine molecule. In addition, three
other subnetworks (Fig. 5g-5i) we discovered further
confirm its potential involvement in obesity, because all
these three pathways contain L-homocysteine as meta-
bolite. It is well-known that a high level of blood serum
homocysteine is a risk factor for cardiovascular disease
[18], and obesity — an increasingly prevalent metabolic
disorder — is closely associated with heart disease [19].
Significant correlations between plasma homocysteine
concentrations and obesity have been previously
reported [18,20-23]. The finding of increased potential
for homocysteine metabolism within the obese gut
microbiome provides an interesting hypothesis for
future studies that, the gut microbiome may either have
a direct role in the elevation of homocysteine levels in
Figure 3 Comparison of statistical methods for discovering significantreactions in simulated datasets.Four methods are evaluated:
discovering active subnetworks using simulatedannealing (Anneal) and greedy search (Greedy) [13], discovering significantindividual reactions
using Metastats [9], finding differentially abundant KEGGdefinedpathways (KEGGPath), and MetaPath. Four datasets are created by varyingthe
number of significant reactions n and their significances.
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of this amino-acid in the human body.
Infant and adult individuals
A second data-set comprises gut microbiome samples
from 4 infants and 9 adults individuals which were
sequenced by Kurokawa, et al., 2007 [7]. The sequences
were annotated and mapped to the reactions of KEGG
pathway using BLASTX (E value < 10
-8, hit length cov-
erage ≥ 50% of a query sequence), resulting in total
1781 unique reactions within the 13 metagenomic sam-
ples. Based on 10 runs of Metastats, 383.7±1.56 reac-
tions are significant using p v a l u ec u t o f fo f0 . 0 5 ,
including 268.7±1.56 and 115±0 reactions enriched in
infant and adult subjects respectively.Using a q value
cutoff of 0.05, 167.2±2.7 reactions are significant,
including 133.2±2.7 and 34±0 reactions enriched in
infant and adult subjects respectively.Compared with the
previous dataset (obese and lean twins samples), the
predictions of significant reactions are much more con-
sistent across different permutations.
Applying MetaPath to search for significant subnet-
works using the same parameters as before, we have
f o u n dt h a t6a r ee n r i c h e di ni n f a n ts u b j e c t s( F i g .6 a - 6 f )
and 4 are enriched in adult subjects (Fig. 6g-6j). These
10 significant subnetworks contain 55 unique reactions
(35 and 20 in subnetworks enriched in infant and adult,
respectively), including 38 significant reactions (22 and
16 enriched in infant and adult, respectively) and 17
reactions not found significant by Metastats. Three sub-
networks enriched in infant subjects (Fig. 6a, 6c and 6d)
involve the metabolite L-homocysteine, and a fourth
Figure 4 p values distributions from comparing individual metabolicreactions by Metastats and from comparing metabolic networks
by MetaPath.The top histogram is the distribution of the p values of individual metabolic reactionscalculated by Metastats. The Bottom
histogram is the distribution of the pabund valuesof the subnetworks calculated by MetaPath.
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Page 8 of 12Figure 5 9 statistically significant subnetworks are found in the comparisonof the gut microbiome from the obese and lean subjects.
All these subnetworks are enriched in the obese subjects. pabund and pstruct significancevalues are shown above each subnetwork. p values for
each reaction are shown withthe KEGG reaction number. Five pathways (a)-(e) belong to the Fatty AcidMetabolism pathway in KEGG. Four
pathways (f)-(i) contain the L-Homocysteinemolecules.
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Page 9 of 12Figure 6 10 statistically significant subpathways are found in the infant andadult individuals dataset.6 subpathways are enriched in the
infant subjects (Fig. 4a-4f), and 4 subpathways areenriched in the adult subjects (Fig. 4g-4j). pabund and pstruct significance values areshown
above each pathway. p values for each reaction are shown with the KEGGreaction number.
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which is consistent with previous observation that
breastfed babies have an higher plasma homocysteine
level possibly caused by suboptimal availability of folate
in breast milk [24]. The concentration of folate is nega-
tively correlated with that of homocysteine, as folate is a
necessary coenzyme for reactions that metabolize homo-
cysteine. In addition, babies normally have high protein
diet, which may also cause the concentration of homo-
cysteine to increase. A second pathway in Fig. 6e
involves substrates citrate and succinate, and is closely
related with oxidative tricarboxylic acid (TCA) cycle.
TCA cycle is part of carbohydrate metabolism and can
convert carbohydrates into usable energy in aerobic
organisms. Because the adult gut ecosystem is domi-
nated by strict anaerobes, it is reasonable to find this
subpathway enriched in infant individuals where the gut
microbiota also includes aerobes. This finding is consis-
tent with results obtained by comparing COG functional
categories [7]. We also find a subpathway belonging to
atrazine metabolism to be enriched in infant subjects
(Fig. 6f). Atrazine is one of the most widely used herbi-
cides, and it contaminates water and soil throughout the
world. Our finding possibly indicates a side-effect of this
contamination.
The pathway in Fig. 6i (enriched in adult subjects) is
part of the lipopolysaccharide biosynthesis. Lipopoly-
saccharides are a building block of the outer mem-
brane of Gram-negative bacteria. The enrichment of
pathway Fig. 6i in adult subject may be a result of the
fact that Gram-negative bacteria are also enriched in
adults. Specifically, Bacteroides, a genus of Gram-nega-
tive bacteria, are a major constituent of adult gut
microbiome, but not highly prevalent in infants. Fig.
6h and Fig. 6j (enriched in adult) are pathways related
with pyrimidine metabolism. The metabolites RNA,
cytidine and uridine, which are contained in pyrimi-
dine metabolism, are normally obtained from high
RNA food such as organ meats, broccoli, and brewer’s
yeast, which are not available to unweaned infants, as
they are not present in high abundance in milk. The
pathway in Fig. 6g (enriched in adult) is part of fruc-
tose and mannose metabolism a pathway related to
carbohydrate metabolism. This is also consistent with
COG-based analyses indicating that many mono- or
disaccharides metabolism genes are enriched in adults
[7], explained by the fact that colonic microbiota in
adults uses indigestible polysaccharides as resources
for energy production and biosynthesis of cellular
components.
Conclusions
We have introduced a statistical method for finding sig-
nificant metabolic subpathways from metagenomic
datasets. Compared with previous methods, results from
MetaPath are more robust to noise in the data, and
have significantly higher sensitivity and specificity (when
tested on simulated datasets). When applied to two pub-
licly available metagenomic data-sets the output of
MetaPath is consistent with previous observations and
also provides several new insights into the metabolic
activity of the gut microbiome. Finally, MetaPath is effi-
cient: a typical metagenomic dataset and the corre-
sponding metabolic network (about 2000 edges) can be
analyzed in half an hour on a single processor.
While showing promising results, our methods have
several limitations that we plan to address in the near
future. First, and foremost, we restrict ourselves to path-
ways of a fixed length — a restriction necessary for
accurately computing the null distribution of pathway
scores. This can severely affect our ability to discover
long pathways whose abundance differs only slightly,
but significantly, between samples. Second, we currently
estimate gene abundances by simply counting the num-
ber of sequencing reads that map to a certain gene.
Such an approach ignores differences in the length of
genes, potentially leading to incorrect conclusions. We
plan to address this issue by incorporating a recently-
published [12] method that can accurately correct for
gene-length effects. The software described in this paper
is freely-available under an open-source license from
http://metapath.cbcb.umd.edu
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